Alseres Pharmaceuticals, Inc.
| OTC Markets: ALSE
Alseres Pharmaceuticals, Inc. is a biotechnology company, which focuses on diagnostic products primarily for disorders in the central nervous system. Its clinical product candidate is called Altropane. The company's molecular imaging program focuses on the diagnosis of Parkinsonian Syndromes and Dementia with Lewy Bodies. It changed its name from Boston Life Sciences, Inc. to Alseres Pharmaceuticals, Inc. The company was founded on October 16, 1992 and is headquartered in Hopkinton, MA.